Akamai and Queue-it Team up to Deliver a Cure for COVID Vaccine Registration Frustration
Akamai Edge Platform and Queue-It’s Virtual Waiting Room Technology Help Minimize Citizen Stress and Reduce the Risk of Vaccine Registration Website Crashes.
Akamai Technologies, Inc., the world’s most trusted solution for protecting and delivering digital experiences, announces a strategic partnership with Queue-it, a leader in virtual waiting room software and services, to meet the historic challenge posed by COVID-19 vaccination. The partnership is focused on helping governments and health systems worldwide handle spikes in registration w**********, while ensuring fairness and providing a user experience that reduces uncertainty and stress.
The solution generated through the partnership, Akamai Vaccine Edge, addresses a critical problem: sudden spikes in vaccination registration traffic that overload websites, preventing citizens from registering. With Vaccine Edge, when traffic exceeds capacity, visitors are redirected to a waiting room that displays queue position, estimated wait time, and additional information to keep registrants informed. As site capacity allows, visitors in the waiting room are automatically admitted to the registration site on a first-come, first-served basis.
Recommended AI News: Tempered Combines Strengths with Nozomi Networks to Deliver Industry-Leading IoT/OT Security
The Vaccine Edge solution keeps visitors informed of their place in line and their estimated waiting time. This can help ensure fairness and reduce the anxiety and stress associated with the process, minimizing user complaints. The waiting room experience is branded for the agency or institution hosting the registration site and can be customized with visitor communications, such as reminders of important information required for their vaccine registration.
Vaccine Edge is designed for easy, one-day deployment. No sensitive data goes through the Vaccine Edge solution, helping ensure compliance with patient privacy regulations. The solution offers all the advantages of the Akamai edge platform on which it resides, including high security, low latency, and extreme scalability.
Vaccine Edge is available now from Akamai and has already been deployed in several U.S. states and Canadian provinces.
Recommended AI News: CipherTrace Announces Cryptocurrency Travel Rule Solution for Regulatory Compliance
“Ensuring individuals can successfully register for the COVID-19 vaccine and stay informed of progress is a powerful example of the value edge computing can deliver,” said Lelah Manz, SVP, Edge Product and Business Strategy for Akamai. “Our partnership with Queue-it will make a real difference for millions of people at a critical time. We believe it’s proof of Akamai’s ability to enable third-party solutions to deliver transformative impact. We look forward to building on this success with other use cases that require a secure virtual waiting room solution at the edge.”
Niels Henrik Sodemann, CEO and Co-founder of Queue-it, emphasized the shared mission behind the partnership. “Akamai shares our goal to help governments and health systems accelerate vaccine distribution in a way that supports fairness and reduces peoples’ stress levels,” he said. “We could not have found a better partner in this endeavor than Akamai. The mutual respect and cooperation has delivered a market-ready solution in record time. We are immensely proud of our role in helping address one of the most pressing health challenges of our time.”
Recommended AI News: Tempered Combines Strengths with Nozomi Networks to Deliver Industry-Leading IoT/OT Security
Comments are closed.